NCT02263976 Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BEA 2180 BR in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02262858 Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II Status COMPLETED Phase PHASE1
NCT02262793 Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects Status COMPLETED Phase PHASE1
NCT02262780 Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02262650 Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female Subjects Status COMPLETED Phase PHASE1
NCT02262637 Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT) Status COMPLETED Phase N/A
NCT02262624 Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02262611 Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo) Status COMPLETED Phase N/A
NCT02262598 Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02262585 Bioequivalence of BIBR 277 Tablet (Mannitol Based) Compared With Capsule Formulation in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02262572 Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects Status COMPLETED Phase PHASE1
NCT02262559 Bioequivalence of BIBR 277 Tablet Compared With Capsule in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02262546 Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02261129 Bioequivalence of Telmisartan Film-coated Tablet Compared With Two Tablets of the Conventional Telmisartan Tablet in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02261116 Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy Volunteers Status COMPLETED Phase PHASE4
NCT02261103 Bioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02261090 Bioavailability of Different Pramipexole Slow-release Formulations Compared to Immediate-release Tablet in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02261077 Pharmacokinetics, Safety and Tolerability of Rising Doses of Buscopan® in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02261064 Influence of Food on the Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Japanese Male Volunteers Status COMPLETED Phase PHASE1